Tag: immunosuppressants

Posted on

Azathioprine Pharmacology

Podcast: Play in new window | Download (Duration: 14:35 — 20.0MB) | Embed

Subscribe: RSS | More

On this episode, I discuss azathioprine pharmacology, adverse effects, monitoring parameters, and drug interactions.

Azathioprine is classified as an immunosuppressive agent so it is naturally going to be used for autoimmune type disorders and transplantation.

Azathioprine has a boxed warning for myelosuppression. I talk more about this in the episode.

Genetic testing is recommended by the AGA prior to the use of azathioprine. I discuss which tests might be helpful to reduce the risk of toxicity.

Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!

Support The Podcast and Check Out These Amazing Resources!

NAPLEX Study Materials

BCPS Study Materials

BCACP Study Materials

BCGP Study Materials

BCMTMS Study Materials

Meded101 Guide to Nursing Pharmacology (Amazon Highly Rated)

Guide to Drug Food Interactions (Amazon Best Seller)

Pharmacy Technician Study Guide by Meded101

Posted on

Cyclosporine Pharmacology

cyclosporine pharmacology

Podcast: Play in new window | Download (Duration: 14:40 — 20.7MB) | Embed

Subscribe: RSS | More

On this episode, I discuss cyclosporine pharmacology. This medication is an immunosuppressant used to reduce the risk of transplant rejection.

Cyclosporine has a long list of potential adverse effects such as hyperglycemia, renal impairment, GI toxicity, and hypertriglyceridemia.

Important monitoring parameters for cyclosporine include drug levels, electrolytes, renal function, and blood sugars.

CYP3A4 interactions are critical with cyclosporine. Inhibitors can raise concentrations and inducers can lower concentrations.

Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!

Posted on

Leflunomide Pharmacology

leflunomide pharmacology

Podcast: Play in new window | Download (Duration: 12:05 — 16.6MB) | Embed

Subscribe: RSS | More

On this episode, I discuss leflunomide pharmacology. It is classified as a DMARD and is primarily used in rheumatoid arthritis.

Leflunomide carries a boxed warning for hepatoxicity. LFTs must be monitored with its use.

Leflunomide can inhibit CYP2C8 which plays an important role in pioglitazone metabolism. Concentrations of pioglitazone can go up on account of this interaction.

TB screening should be done prior to beginning the immunosuppressant leflunomide.

I discuss important drug interactions on the podcast, be sure to check out my latest project which is a 200+ page book on managing drug interactions in primary care.

Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!

Posted on

Tacrolimus Pharmacology

Podcast: Play in new window | Download (Duration: 14:40 — 20.7MB) | Embed

Subscribe: RSS | More

On this episode, I discuss tacrolimus pharmacology. This medication is an immunosuppressant used to reduce the risk of transplant rejection.

Tacrolimus has a long list of potential adverse effects such as hyperglycemia, renal impairment, GI toxicity, and hypertriglyceridemia.

Important monitoring parameters for tacrolimus include drug levels, electrolytes, renal function, and blood sugars.

CYP3A4 interactions are critical with tacrolimus. Inhibitors can raise concentrations and inducers can lower concentrations.

Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!